Literature DB >> 10195445

Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.

S Y Shin1, J H Kang, K S Hahm.   

Abstract

In order to elucidate the structure-antibiotic activity relationship of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides, several truncated peptides and the analogues with amino acid substitutions were synthesized and their antibacterial, antitumor and hemolytic activities of were examined. Cecropin A-magainin 2 hybrid analog, L16-CA(1-8)-MA(1-12) (termed as L-CA-MA in this study: KWKLFKKIGIGKFLHLAKKF-NH2), is known to have potent antibacterial and antitumor activity with less hemolytic activity. We found that the C-terminal region of L-CA-MA is more involved in the alpha-helical structure on cell membrane-like environment than N-terminal one by circular dichroism analysis. Deletion of the Gly-Ile-Gly sequence, the central hinge region of L-CA-MA, produced a considerable reduction in antitumor and hemolytic activity rather than an antibacterial one. The insertion of Pro, Gly-Ile or Gly-Pro in this hinge region of L-CA-MA caused retention of both antibacterial and antitumor activity while causing a significant decrease in hemolytic activity. However, the substitution with Gly-Pro-Gly instead of the Gly-Ile-Gly in CA(1-8)-MA(1-12), CA(1-8)-ME(1-12), CA(1-13)-MA(1-13) and CA(1-13)-ME(1-13) hybrids resulted in a drastic decrease in antibacterial, antitumor and hemolytic activity. The increase of hydrophobicity at position 16 in CA(1-8)-MA(1-12) by substituting Trp or Phe induced a significant increase in hemolytic activity without a considerable change in either antibacterial or antitumor activity. Therefore, these results suggested that the appropriate flexibility in the hinge region of CA-MA and CA-ME hybrid peptides and the appropriate hydrophobicity at position 16 in the hydrophobic region of CA (1-8)-MA(1-12) are important in potent antibacterial and antitumor activity with no hemolytic effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195445     DOI: 10.1111/j.1399-3011.1999.tb01620.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  14 in total

Review 1.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

2.  In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens.

Authors:  Stephane Desgranges; Florie Le Prieult; Alan Daly; Jennifer Lydon; Marian Brennan; Dilip K Rai; Anusha P Subasinghage; Chandralal M Hewage; Sally-Ann Cryan; Catherine Greene; Noel G McElvaney; Timothy P Smyth; Deirdre Fitzgerald-Hughes; Hilary Humphreys; Marc Devocelle
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.

Authors:  Y H Yau; B Ho; N S Tan; M L Ng; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.

Authors:  Indresh Kumar Maurya; Chaitanya Kumar Thota; Sachin Dev Verma; Jyotsna Sharma; Manpreet Kaur Rawal; Balaguru Ravikumar; Sobhan Sen; Neeraj Chauhan; Andrew M Lynn; Virander Singh Chauhan; Rajendra Prasad
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

5.  Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30).

Authors:  Rujuan Wu; Qing Wang; Zhaojun Zheng; Longmei Zhao; Yajing Shang; Xubiao Wei; Xiudong Liao; Rijun Zhang
Journal:  Mol Biol Rep       Date:  2014-05-29       Impact factor: 2.316

6.  Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.

Authors:  Eanna Forde; Hilary Humphreys; Catherine M Greene; Deirdre Fitzgerald-Hughes; Marc Devocelle
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

7.  Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.

Authors:  Lily Johanna Toro Segovia; Germán Alberto Téllez Ramírez; Diana Carolina Henao Arias; Juan David Rivera Duran; Juan Pablo Bedoya; Jhon Carlos Castaño Osorio
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

8.  Group A Streptococcal S Protein Utilizes Red Blood Cells as Immune Camouflage and Is a Critical Determinant for Immune Evasion.

Authors:  Igor H Wierzbicki; Anaamika Campeau; Diana Dehaini; Maya Holay; Xiaoli Wei; Trever Greene; Man Ying; Jenna S Sands; Anne Lamsa; Elina Zuniga; Kit Pogliano; Ronnie H Fang; Christopher N LaRock; Liangfang Zhang; David J Gonzalez
Journal:  Cell Rep       Date:  2019-12-03       Impact factor: 9.423

9.  Novel Hybrid Peptide Cecropin A (1-8)-LL37 (17-30) with Potential Antibacterial Activity.

Authors:  Xu-Biao Wei; Ru-Juan Wu; Da-Yong Si; Xiu-Dong Liao; Lu-Lu Zhang; Ri-Jun Zhang
Journal:  Int J Mol Sci       Date:  2016-06-29       Impact factor: 5.923

Review 10.  Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.

Authors:  Darren Shu Jeng Ting; Roger W Beuerman; Harminder S Dua; Rajamani Lakshminarayanan; Imran Mohammed
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.